Overview

Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To compare safety and efficacy of Perrigo's rosacea drug product compared to an FDA approved rosacea drug product in the treatment of facial erythema of rosacea.
Phase:
Phase 3
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Treatments:
Brimonidine Tartrate